142 related articles for article (PubMed ID: 37326897)
21. LncRNA HOTTIP promotes the proliferation and invasion of ovarian cancer cells by activating the MEK/ERK pathway.
Liu J; Hu HB; Liu YM; Li FX; Zhang LP; Liao ZM
Mol Med Rep; 2020 Nov; 22(5):3667-3676. PubMed ID: 33000231
[TBL] [Abstract][Full Text] [Related]
22. Migration of gastric cancer is suppressed by recombinant Newcastle disease virus (rL-RVG) via regulating α7-nicotinic acetylcholine receptors/ERK- EMT.
Bu X; Zhang A; Chen Z; Zhang X; Zhang R; Yin C; Zhang J; Zhang Y; Yan Y
BMC Cancer; 2019 Oct; 19(1):976. PubMed ID: 31640627
[TBL] [Abstract][Full Text] [Related]
23. LncRNA CERS6-AS1 promotes proliferation and metastasis through the upregulation of YWHAG and activation of ERK signaling in pancreatic cancer.
Xu J; Wang J; He Z; Chen P; Jiang X; Chen Y; Liu X; Jiang J
Cell Death Dis; 2021 Jun; 12(7):648. PubMed ID: 34168120
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of LONP1 Suppresses Pancreatic Cancer Progression Via c-Jun N-Terminal Kinase Pathway-Meditated Epithelial-Mesenchymal Transition.
Liu C; Wang H; Li H; Chen X; Wu X; Lu B; Zhang W; Zhou Y; Xiao GG; Gao G
Pancreas; 2019; 48(5):629-635. PubMed ID: 31091208
[TBL] [Abstract][Full Text] [Related]
25. NFIC1 inhibits the migration and invasion of MDA-MB-231 cells through S100A2-mediated inactivation of MEK/ERK pathway.
Zhang J; Wang Z; Liang Z; Jin C; Shi Y; Fan M; Hu X; Wan Y
Arch Biochem Biophys; 2023 Jan; 734():109497. PubMed ID: 36574914
[TBL] [Abstract][Full Text] [Related]
26.
Wang K; Chu Y; Zhang H; Qu X; Wang B; Han Y
Comb Chem High Throughput Screen; 2024; 27(3):436-445. PubMed ID: 37151068
[TBL] [Abstract][Full Text] [Related]
27. RIPK4/PEBP1 axis promotes pancreatic cancer cell migration and invasion by activating RAF1/MEK/ERK signaling.
Qi ZH; Xu HX; Zhang SR; Xu JZ; Li S; Gao HL; Jin W; Wang WQ; Wu CT; Ni QX; Yu XJ; Liu L
Int J Oncol; 2018 Apr; 52(4):1105-1116. PubMed ID: 29436617
[TBL] [Abstract][Full Text] [Related]
28. GABA(A) receptor pi (GABRP) stimulates basal-like breast cancer cell migration through activation of extracellular-regulated kinase 1/2 (ERK1/2).
Sizemore GM; Sizemore ST; Seachrist DD; Keri RA
J Biol Chem; 2014 Aug; 289(35):24102-13. PubMed ID: 25012653
[TBL] [Abstract][Full Text] [Related]
29. CD133 facilitates epithelial-mesenchymal transition through interaction with the ERK pathway in pancreatic cancer metastasis.
Ding Q; Miyazaki Y; Tsukasa K; Matsubara S; Yoshimitsu M; Takao S
Mol Cancer; 2014 Jan; 13():15. PubMed ID: 24468059
[TBL] [Abstract][Full Text] [Related]
30. EGF/EGFR Promotes Salivary Adenoid Cystic Carcinoma Cell Malignant Neural Invasion
Ren Y; Hong Y; He W; Liu Y; Chen W; Wen S; Sun M
Curr Cancer Drug Targets; 2022; 22(7):603-616. PubMed ID: 35410600
[TBL] [Abstract][Full Text] [Related]
31. LAGE3 promoted cell proliferation, migration, and invasion and inhibited cell apoptosis of hepatocellular carcinoma by facilitating the JNK and ERK signaling pathway.
Xing Y; Liu Y; Qi Z; Liu Z; Wang X; Zhang H
Cell Mol Biol Lett; 2021 Nov; 26(1):49. PubMed ID: 34837962
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-338-3p suppresses ovarian cancer cells growth and metastasis: implication of Wnt/catenin beta and MEK/ERK signaling pathways.
Zhang R; Shi H; Ren F; Feng W; Cao Y; Li G; Liu Z; Ji P; Zhang M
J Exp Clin Cancer Res; 2019 Dec; 38(1):494. PubMed ID: 31842953
[TBL] [Abstract][Full Text] [Related]
33. HOXA3 promotes tumor growth of human colon cancer through activating EGFR/Ras/Raf/MEK/ERK signaling pathway.
Zhang X; Liu G; Ding L; Jiang T; Shao S; Gao Y; Lu Y
J Cell Biochem; 2018 Mar; 119(3):2864-2874. PubMed ID: 29073728
[TBL] [Abstract][Full Text] [Related]
34. TAF15 promotes cell proliferation, migration and invasion of gastric cancer via activation of the RAF1/MEK/ERK signalling pathway.
Tang L; Guo C; Li X; Zhang B; Huang L
Sci Rep; 2023 Apr; 13(1):5846. PubMed ID: 37037864
[TBL] [Abstract][Full Text] [Related]
35. Increased semaphorin 3c expression promotes tumor growth and metastasis in pancreatic ductal adenocarcinoma by activating the ERK1/2 signaling pathway.
Xu X; Zhao Z; Guo S; Li J; Liu S; You Y; Ni B; Wang H; Bie P
Cancer Lett; 2017 Jul; 397():12-22. PubMed ID: 28315433
[TBL] [Abstract][Full Text] [Related]
36. Silencing of linc00337 inhibits proliferation, cell cycle progression, migration, and invasion of colorectal cancer cells through the MEK/ERK pathway.
Wang ZG; Yang YG; Fu GS; Lu DH; Tian SY; Wei W
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5353-5359. PubMed ID: 32495869
[TBL] [Abstract][Full Text] [Related]
37. MEK/ERK-mediated proliferation is negatively regulated by P38 map kinase in the human pancreatic cancer cell line, PANC-1.
Ding XZ; Adrian TE
Biochem Biophys Res Commun; 2001 Mar; 282(2):447-53. PubMed ID: 11401480
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-330-3p promotes cell invasion and metastasis in non-small cell lung cancer through GRIA3 by activating MAPK/ERK signaling pathway.
Wei CH; Wu G; Cai Q; Gao XC; Tong F; Zhou R; Zhang RG; Dong JH; Hu Y; Dong XR
J Hematol Oncol; 2017 Jun; 10(1):125. PubMed ID: 28629431
[TBL] [Abstract][Full Text] [Related]
39. Along with its favorable prognostic role, CLCA2 inhibits growth and metastasis of nasopharyngeal carcinoma cells via inhibition of FAK/ERK signaling.
Qiang YY; Li CZ; Sun R; Zheng LS; Peng LX; Yang JP; Meng DF; Lang YH; Mei Y; Xie P; Xu L; Cao Y; Wei WW; Cao L; Hu H; Yang Q; Luo DH; Liang YY; Huang BJ; Qian CN
J Exp Clin Cancer Res; 2018 Feb; 37(1):34. PubMed ID: 29463274
[TBL] [Abstract][Full Text] [Related]
40. FLOT2 Promotes the Proliferation and Epithelial-mesenchymal Transition of Cervical Cancer by Activating the MEK/ERK1/2 Pathway.
Li Y; Dou S
Balkan Med J; 2022 Jul; 39(4):267-274. PubMed ID: 35872627
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
